Nuvation Bio execs to present at multiple healthcare conferences in May 2026

Nuvation Bio Inc., a global oncology company, announced that its CEO David Hung and CFO Philippe Sauvage will participate in several fireside chats and one-on-one meetings at major healthcare conferences throughout May 2026. These include events hosted by Bank of America Securities, H.C. Wainwright, RBC Capital Markets, and TD Cowen, with sessions held both in-person and virtually. The company focuses on developing innovative cancer therapies, including next-generation inhibitors and drug conjugates. Live webcasts of these presentations will be available on Nuvation Bio's website, providing investors and stakeholders insight into the company's progress and strategy.